Putnam Investments LLC Natera, Inc. Transaction History

Putnam Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $3 Million - $9.02 Million	-98,797 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $1.2 Million - $1.66 Million	13,908 Added 16.38%	98,797 $9.23 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $39,066 - $49,280	-390 Reduced 0.46%	84,889 $9.46 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $14,026 - $19,514	-163 Reduced 0.19%	85,279 $9.68 Million
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $6,402 - $8,705	-70 Reduced 0.08%	85,442 $8.68 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $5.7 Million - $9.56 Million	85,512 New	85,512 $8.51 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.